Borgsdorf L R, Miano J S, Knapp K K
Kaiser Permanente, Bakersfield, CA.
Am J Hosp Pharm. 1994 Mar 15;51(6):772-7.
A medication-review service at a managed care facility was studied. The service, developed in 1991, provides in-depth analysis of medication use and patient consultation by a pharmacist. Patients are seen by referral. During a visit, the pharmacist reviews each medication for patterns of use, clinical response, and adverse effects and if necessary teaches the patient how to use the drugs more appropriately. The pharmacist may change some aspect of the prescription and may schedule follow-up visits. The investigators reviewed data on (1) medication-related problems for all new patients seen by the pharmacist during the first 12 months of the service, (2) patient demographics for the first 23 months, (3) utilization of the service and pharmacist productivity for the first 23 months, (4) utilization of medications and health care services in a representative subset of patients 12 months before and after they used the service, and (5) costs. A total of 2720 medications were reviewed during months 1-12. On average, 64.9% of the drugs reviewed each month were problematic. A total of 836 patients were seen during the first 23 months; most of the referrals were from physicians. The patients averaged 2.6 diagnoses and 4.7 drugs each and were not dominated by any one age group, gender, diagnosis, or drug therapy. A representative subgroup showed reductions in the number of unscheduled physician visits, urgent care visits, emergency room visits, and hospital days; a savings of $644 per patient per year was calculated. Patients used fewer health services during the year after they began participating in a pharmacist-managed medication-review program.
对一家管理式医疗保健机构的药物审查服务进行了研究。该服务于1991年推出,由药剂师对药物使用情况进行深入分析并为患者提供咨询。患者通过转诊前来就诊。在就诊期间,药剂师会审查每种药物的使用模式、临床反应和不良反应,必要时还会教导患者如何更合理地用药。药剂师可能会更改处方的某些方面,并安排后续就诊。研究人员审查了以下数据:(1)该服务开展的前12个月内药剂师诊治的所有新患者的药物相关问题;(2)前23个月的患者人口统计学数据;(3)前23个月该服务的使用情况和药剂师的工作效率;(4)使用该服务的患者在使用服务前后12个月内一个具有代表性的子集中药物和医疗服务的使用情况;(5)成本。在第1至12个月期间共审查了2720种药物。平均而言,每月审查的药物中有64.9%存在问题。在前23个月内共诊治了836名患者;大多数转诊来自医生。这些患者平均每人有2.6种诊断和4.7种药物,且不存在任何一个年龄组、性别、诊断或药物治疗占主导的情况。一个具有代表性的亚组显示,非预约医生就诊、紧急护理就诊、急诊室就诊次数和住院天数有所减少;计算得出每位患者每年节省644美元。患者在开始参与药剂师管理的药物审查项目后的一年中使用的医疗服务较少。